Bullish
CRISPR Therapeutics stock (CH0334081137): Bernstein raises price target amid gene-editing momentum
Bernstein has raised its price target for CRISPR Therapeutics (CH0334081137) to $56, maintaining its rating and reflecting confidence in the gene-edit...